文献速递小儿神经外科与脑积水神经重症

导水管通畅的成人长期显性脑室扩大(LOVA):手术结局与病因探讨

Longstanding overt ventriculomegaly in adults (LOVA) with patent aqueduct: surgical outcome and etiopathogenesis of a possibly distinct form of chronic hydrocephalus.
PubMed 文献 · Acta Neurochir (Wien) · 2021-09-07

ETV组66.7%获得成功结局,并发症率11.1%;VPS组100%获得满意结局,并发症率25%。作者认为导水管通畅的LOVA可能是慢性脑积水的独立临床亚型,ETV仍可作为一线治疗选择。

要点

  • 导水管通畅的LOVA患者中,ETV作为首选治疗可获得较好结局且并发症率较低。
  • ETV失败后行补救性VPS仍可获得良好结局。
  • 作者提出该类脑积水可能源于「脑池内」梗阻,支持ETV的病理生理学依据。

核心结论

  • 导水管通畅的LOVA可能代表一种独立的慢性脑积水临床亚型。
  • 对于该亚组,ETV因结局良好且并发症率低,仍可作为可接受的一线治疗选择。

研究设计与样本

  • 中位年龄70岁,收集术前影像与临床特征、手术方式(VPS或ETV)及结局。
  • 成功结局定性定义为随访时症状改善或进展停止,定量采用mRS和iNPHGS量表变化。

主要发现

  • ETV组6例(66.7%)获得成功结局,并发症率11.1%;2例ETV失败后行补救VPS均获良好结局。
  • VPS组4例(100%)获得满意结局,并发症率25%。

关键数值与推荐

  • 成功结局定性标准:随访时症状改善或进展停止。
  • 定量评估采用mRS和iNPHGS量表的变化。

临床怎么用

  • 对导水管通畅的LOVA患者,可考虑将ETV作为首选手术方式。
  • ETV失败后仍可选择补救性VPS,且可获得良好结局。

局限性

  • 失访率较高(22.2%),可能影响结局评估的可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Longstanding overt ventriculomegaly in adults (LOVA) represents a form of chronic adulthood hydrocephalus with symptomatic manifestation in late adulthood. Based on the patency of the aqueduct, two different subcohorts of LOVA can be distinguished. Surgical treatments of this condition are also debated. Therefore, we analyzed preoperative characteristics and clinical outcome after different surgical treatments in a subgroup of LOVA patients with a patent aqueduct. METHODS: Eighteen LOVA patients with a patent aqueduct consecutively treated at our institution between July 2013 and December 2019 were analyzed for this study. Median age was 70 years. Preoperative radiological and clinical features, surgical procedures (ventriculo-peritoneal shunt or endoscopic third ventriculostomy), and outcomes were collected. Successful outcome was qualitatively defined as an improvement or a halt of progression of the presenting symptoms at follow-up, and quantitatively by changes in mRS and iNPHGS scales. RESULTS: Twelve patients underwent an ETV as a primary treatment, while 6 underwent VPS. A total of 22.2% of them were lost to follow-up. Median follow-up time was 38 months. Six patients (66.7%) in the ETV cohort achieved a successful outcome after treatment, with a complication rate of 11.1%. Two patients underwent rescue VPS after ETV failure with a good outcome. Four patients (100%) underwent primary VPS and achieved a satisfactory outcome after treatment, with a reported complications rate of 25%. CONCLUSION: LOVA with patent aqueduct represents, in our opinion, a distinct clinical form of chronic hydrocephalus. For this subgroup, as well as for other forms of LOVA, ETV remains an acceptable first-line treatment option considering the good results, and the low complication rate, obtained in those patients and the hypothesis that hydrocephalus is due to an "intracisternal" obstruction.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Palandri G, Carretta A, La Corte E, et al. Longstanding overt ventriculomegaly in adults (LOVA) with patent aqueduct: surgical outcome and etiopathogenesis of a possibly distinct form of chronic hydrocephalus. Acta Neurochir (Wien). 2021. PMID: 34491433. doi:10.1007/s00701-021-04983-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。